Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Asian Hematology 2020

About Conference


After the productive venture of series of hematology conferences around the globe Conference Series LLC Ltd  is overwhelmed to welcome all the participants to CME Accredited “World Summit on Hematology and Cell Therapy” will held on August 07-08, 2020 at Osaka, Japan. The CME Accredited conference is going to be organized round the theme"A challenging exploration on Hematology and Cell Therapy which incorporates prompt keynote presentations, Oral talks, Poster displays and Exhibitions. CME Accredited 2020 is twelfth successive conference of Hematology Conference series that is a global platform to discuss and learn about Hematology, Blood Disorders, Hematologic Oncology, Hematologic Disorders, Immunohematology and Blood Disorders: Diagnosis & Treatment, Clinical and Experimental Hematology, Hematopathology, Pediatric Hematology, Veterinary Hematology, Hematology Nursing, Stem Cell Research and much more.

 

Tracks/Sessions

Track 1: Hematology

Hematology is the science which deals with blood and its disorders and blood forming organs and this science includes the diagnosis, treatment, prevention towards diseases related to blood and malignance`s like hemophilia, leukemia, lymphoma and sickle-cell anemia. Hematology mainly focuses on blood components like blood cells, hemoglobin, blood proteins, bone marrow, spleen and coagulation mechanism.

Hematologists make sure of blood levels if the levels either highly elevated or depleted physician go with bone marrow aspiration. Varying or low rates of synthesis in haemoglobin leads to anaemia and also bleeding disorders and failure of coagulation mechanism, polycythaemia a disease condition where we can observe elevation of red blood cells Hematologists treat this state by employing phlebotomy taking the root cause into consideration that is reducing the haematocrit levels all these conditions come under Hematopathology.

Physicians who work on treating hematologic disorders, referred to as Hematologists. Some Hematologists also maintains laboratory who were referred hematopathologists they work on to formulate the best diagnosis for treating hematologic disorders, in some cases Hematologists as well hematopathologists both work in conjugation for giving the best therapy.      

  • Anaemia.
  • Blood coagulation mechanism.
  • Polycythemia.
  • Histiocytosis. 
  • Hematologic neoplasms.

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Conference 2020 | International Conference on Hematology  | Hematology Medical Oncology Conference | Hematological Malignances Conference | Blood Conferences | World Hematologists Congress | Hematology Conference 2020 Asia Pacific

European Hematology Societies:
European society of Hematology, British Society of Hematology, International society of Hematology, European society of Paediatric Hematology Oncology, Sociedad Española de Hematology Hemotheraphy

Asian Oncology Societies: Asian Oncology Nursing Society (AONS), Asian Society of Gynecologic Oncology (ASGO), Asian Society of Head & Neck Oncology (ASHNO), Federation of Asian Organizations for Radiation Oncology (ARO)

USA Hematology Societies:
American Society of Hematology, International Society for Laboratory Hematology, The Canadian Hematology Society, Michigan society of Hematology, American Society of Clinical Oncology.

European Oncology Societies: European Society for Gene and Cell Therapy, International Society for Stem Cell Research (ISSCR), UK Oncology Nursing Children’s Cancer and Leukemia Group Society, European Society of Oncologic Imaging, European Association for Cancer Research

Asian Hematology Societies:
Emirates society of Hematology, Saudi Society for Hematology, Haematology Society of Australia and New Zealand, Malaysian society of Hematology, Armenian Hematology Association.

USA Oncology Societies: American Cancer Society (ACS), American Association for Cancer Research (AACR), International Agency for Research on Cancer (IARC), American Society of Clinical Oncology (ASCO)

Track 2: Blood Disorders

Blood disorder is a state where problem is with blood cells and blood components like white blood cells (WBC), circulating platelets and red blood cells (RBC). Any depletion or damaged platelets cause abnormalities in clot formation. Whereas these red blood cells carry oxygen to tissues play a vital role in organ survival decreased oxygen carrying capacity of RBC leads to some disorders like fatigue, shortness of breath, auto immune haemolytic anaemia and also lack of oxygenated blood to brain. Bone marrow dysfunction is the main cause for low levels of white blood cells in some cases WBC gets destroyed by auto immune disorders there by leading to decreased levels and increasing the sort of infections attack.

Depleted levels of leukocytes is a sign that immune system is not having the capacity to handle infections, chronic inflammation utilises leukocytes faster than they are produced leading to dysfunction of bone marrow ultimately triggering the low levels of WBC.

  • Lymphoma.
  • Myelodysplastic syndrome.
  • Von Willebrand disease.
  • Plasma cell myeloma.
  • Primary thrombocythemia.
  • Haemophilia.

 

Asian Hematology Societies:
Emirates society of Hematology, Saudi Society for Hematology, Haematology Society of Australia and New Zealand, Malaysian society of Hematology, Armenian Hematology Association.

Track 3: Blood transfusion

Blood transfusion is the process of receiving whole blood or blood products into one’s systemic circulation intravenously. Transfusion may include injection of whole blood or components such as red blood cells, white blood cells, plasma, platelets or clotting factors. Blood transfusion is usually done in cases of deficiencies, to increase the oxygen saturation, during accidents or during surgery, to treat hematologic conditions such as severe anaemia, leukaemia, and sickle cell disease. Blood transfusion may also be associated with various complications including infections, immunological disorders such as haemolysis or incompatibilities. Hence a very systematic protocol is followed for blood transfusion which includes processing and testing the donor’s blood for possible infectious disorders, particularly for viruses such as Hepatitis B and C, HIV, and West Nile Virus, Compatibility testing and hemovigilance. The system should include monitoring, identification, reporting, investigation and analysis of adverse events near-misses and reactions related to transfusion and manufacturing. Research and advances in this area of Haematology is hence considered a very important aspect.

  • Febrile reactions.
  • Graft versus Host disease (GVHD).
  • Compatibility testing.
  • Autologous blood.

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Conference 2020 | International Conference on Hematology  | Hematology Medical Oncology Conference | Hematological Malignances Conference | Blood Conferences | World Hematologists Congress | Hematology Conference 2020 Asia Pacific

 

Track 4: Immunohematology

Immunohematology referred to be blood banking. This is the laboratory medicine dealing up with preparing blood components, blood for appropriate selection and transfusion and also components that are compatible for transfusion which is helpful in case of severe blood loss or low blood levels. If the selection and compatibility fail this may directs to harm the kidneys, lungs and might be life threating. Transfusion can be recommended in case of illness, burns, cancer, injury. Individuals get immunized when there are previous transfusions of blood or in case of pregnancy. Red blood cells contain antigens and protein markers on their surfaces, if recipient or donors red blood cells doesn’t contain this antigen the antigen lacking individual will lead to form antibodies which destroys the red blood cells.so what blood banks screens, typing and cross matching are carried out for blood and its components before the transfusions.

If immune system of recipient attacks the donor red blood cells this state knows to be hemolytic reaction sometimes hives and itching can also be observed.

  • Transfusion related acute lung injury (TRALI). 
  • Acute kidney failure.
  • Antibody screening.
  • Gel testing.
  • Pre-transfusion testing module.
  • Rh-sensitization.

Track 5: Pediatric Hematology

Pediatric hematology is a branch of hematology dealing with the general hematological problems seen in neonates or pediatric patients. Other issues such as blood counts, Polycythemia, Neonatal anaemia, Anaemia of prematurity, Haemolytic anaemia in the neonate, Congenital red cell defects, acquired red cell defects, Hyperbilirubinemia, Congenital dyserythropoietic anaemia, Acquired red cell aplasia, Neutropenia, leukaemia etc are dealt under Paediatric Haematology. Haematopoiesis is different in pediatric patients and neonates compared to adults. By birth, virtually all bone marrow cavities are actively hematopoietic. In childhood, hematopoiesis moves to central bones (vertebrae, sternum, ribs, pelvis). The red cells of the new-born are macrocytic and the blood film from a new-born infant shows macrocytic normochromic cells, polychromasia, and a few nucleated red blood cells. Even in healthy infants there may be mild anisocytosis and poikilocytosis. Blood viscosity, oxygen delivery, Iron and transferring content, red cell antigens and many other features are different in neonates and children compared to the adults. Hence a thorough research enabling a proper diagnosis and treatment of all the haematological disorders in neonates and paediatric patients is highly necessary.

  • Acanthocytosis.
  • Cancer infection control.
  • Thrombocytopenia in new-born.
  • Systemic disorders.

Track 6: Veterinary Hematology

Haematology is a broad concept which deals with topics ranging from haematopoiesis (production of blood cells) to laboratory diagnosis of various diseases through the study of blood. Veterinary Haematology deals with all these aspects of Haematology in animals. Veterinary Haematology is important as there are significant differences in the blood cells of animals from human beings. Mammals have anucleate platelets and erythrocytes while birds and reptiles have nucleus cells. Size of the erythrocytes is also different in different animals. Different mammals have unique responses to inflammation. These differences make the assessment of blood and diagnosis of blood disorders more difficult than mammals, particularly human beings. So study of haematological characteristics of animals is important in diagnosing the disease. In poultry, dairy, meat and other industries involving animals such as sericulture, early diagnosis of these disorders is important in preventing huge financial losses. Veterinary haematology is also important to diagnose, and control infections spread to humans from animals.

  • Erythropoiesis.
  • Hematotoxicity.
  • Haemostasis.
  • Animal case studies and reports.
  • Species specific hematology.

Track 7: Stem cell research

Stem cell research deals with research and publication of high quality manuscripts related to stem cells. Stem cells are cells of multicellular organisms that can differentiate into other types of cells. They can divide more cells of the same type of stem cells. For a cell to be considered a stem cell, it should be self-renewing and must be either totipotent or pluripotent. Various types of stem cells such as embryonic stem cells, foetal and adult stem cells tissue specific stem cells, haemopoietic stem cells, cancer stem cells are known. Haemopoietic stem cells that give rise to other blood cells by a process called Hemopoiesis in the red bone marrow. Haemopoietic stem cell transplants are used in the treatment of cancers and other immune system disorders.

  • Stem cell therapy.
  • Different types of stem cells.
  • Stem cell transplantation.
  • Stem cell biomarkers.
  • Stem cell products.

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Conference 2020 | International Conference on Hematology  | Hematology Medical Oncology Conference | Hematological Malignances Conference | Blood Conferences | World Hematologists Congress | Hematology Conference 2020 Asia Pacific

Track 8: Blood Disorders Diagnosis and Treatment

Initially for detecting the blood disorders bone marrow biopsy will be carried out which involves the study of cytogenetics and surface proteins on bone marrow cells and this study process referred to be flow cytometry. Treating of blood disorder may vary for every particular disorder, this can include use of coagulation factor support, immune modulating therapies, chemotherapy, bone marrow transplantation palliative care must be taken for the patients with complex disorder. Antithrombic are the class of drugs that works in preventing coagulation of blood which can be used in haemodialysis. in preventive measure for life threatening pulmonary emboli cases interventional radiologists implant vena cava filter by the help of ionizing radiation. Generally, through physical examinations, medical reports are used to detect the disorders by physicians to initiate the best therapy.

  • Hemochromatosis.
  • Idiopathic thrombocytopenic purpura.
  • Malaise.
  • Bone marrow transplantation.
  • Blood transfusion.

 Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Conference 2020 | International Conference on Hematology  | Hematology Medical Oncology Conference | Hematological Malignances Conference | Blood Conferences | World Hematologists Congress | Hematology Conference 2020 Asia Pacific

Track 9: Hemato-Oncology

Hematology-oncology is the science applied to treat blood disorders and diseases and(hematology) and cancers (oncology). Also, it treats with blood cancers and some disease include iron deficiency anaemia, thalassemia’s as well other organ cancers. Bone marrow cancers concerns with leukaemia’s in which WBC cancer takes place in this condition bone marrow synthesis other blood cells, initiating to bone tumours state referred to as multiple myeloma in this abnormal protein were created leading kidney dysfunction and can be identified by some symptoms like bone pain, frequent bone breaking and also constipation sometimes, mostly patients with the treatments like chemotherapy, radiation, plasmapheresis. The treatment will vary for individual suffering with myeloma based on many factors, in this multiple myeloma it includes a stage referred smoldering stage in which it doesn’t show active symptoms that is the state in which myeloma cells present in the body were not progressive.

  • Acute lymphoblastic leukaemia.
  • Acute myelogenous leukaemia.
  • Chronic lymphocytic leukaemia.
  • Acute monocytic leukaemia.
  • Hodgkin’s lymphomas.
  • Non-Hodgkin’s lymphomas.

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Conference 2020 | International Conference on Hematology  | Hematology Medical Oncology Conference | Hematological Malignances Conference | Blood Conferences | World Hematologists Congress | Hematology Conference 2020 Asia Pacific 

Track 10: Hematopathology

Hematopathology or hemopathology concerns with the study of diseases and disorders that are affecting the blood cells, and their synthesis and some other tissues involved in haematopoiesis like spleen, bone marrow and the thymus. This include cell kinetics which detects the characteristic neoplastic haematolymphoid cells, metabolic hematology used to find the abnormalities in haemoglobin, cytoskeletal abnormalities and red blood cell enzyme deficiency and used to screen the characteristic thalassemia’s and also molecular hematopathology this analyses RNA or DNA in monitoring hematologic malignance’s and to quantify the genetic abnormalities.

Morphology of hematopathology performs the blood count and identifies cellular morphology in some body fluids and peripheral blood. Treating of diseases like lymphomas and leukaemia come under hematopathology. Physicians who trained to diagnose the diseases of blood are hematopathologists.

  • Hereditary spherocytosis.
  • Metastatic tumours.
  • Thalassemia.
  • Aplastic anaemia.

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Conference 2020 | International Conference on Hematology  | Hematology Medical Oncology Conference | Hematological Malignances Conference | Blood Conferences | World Hematologists Congress | Hematology Conference 2020 Asia Pacific

Track 11: Thalassemia

Thalassemia known to be an inherited blood disorder which is capable of forming abnormal haemoglobin synthesis. It is suspected to be a genetic disorder inherited by parents. This of two types Alpha Thalassemia and Beta Thalassemia this cannot synthesis beta globin, as well thalassemia intermedia which is less severe, the severity depends on no of genes that have been missing Symptoms may vary depending upon the type from mild to severe anaemia, this can lead to tired, pale skin, enlargement of spleen, bone deformities, delayed growth and development and sometimes dark urine in children. Diagnosis include firstly the complete blood count and also genetic tests along with haemoglobin testing. Treatment may vary from the degree of severity and the therapy may include iron chelation, blood transfusions. Iron chelation can be done through deferoxamine, in case of iron overload from transfusions osteoporosis can be a result and spleen become enlarged which needs a surgical removal in emergency.

  • Alpha Thalassemia.
  • Sickle cell trait.
  • Genetic disorders.
  • Osteoporosis.

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Conference 2020 | International Conference on Hematology  | Hematology Medical Oncology Conference | Hematological Malignances Conference | Blood Conferences | World Hematologists Congress | Hematology Conference 2020 Asia Pacific

Track 12: Polymerase Chain Reaction (PCR) in Haematological malignancies

Polymerase chain reaction (PCR) is a technique used in molecular biology to amplify a single or a few copies of a segment of DNA across several orders of magnitude, generating many copies of a particular DNA sequence. PCR has rapidly become an invaluable technique for the detection and clinical management of a wide variety of haematological disorders. It provides a rapid method for the generation of large quantities of relatively pure DNA sequences of interest. This facilitates nucleotide sequence analysis in both normal and pathological haemopoietic populations. It also aids in the characterisation of normal molecular organisation and of inherited and acquired genetic defects. The extreme sensitivity of detection of rare genetic events has greatly improved the ability to detect minimal residual malignancy and low levels of viral infection.  PCR is more advanced in that genetically modifies abnormal cells can be detected within a normal cell population at far low incidence level than any other existing technology. Advancements in PCR help in Detection of Mutated Genes, Detection of Chromosomal Translocations, Detection of Gene Expression, Detection of Clonality and sequencing.

  • Oncogenes.
  • Preleukemic states.
  • Chromosomal translocations.
  • Real-time polymerase chain reaction.
  • Invasive pulmonary fungal infections.

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Conference 2020 | International Conference on Hematology  | Hematology Medical Oncology Conference | Hematological Malignances Conference | Blood Conferences | World Hematologists Congress | Hematology Conference 2020 Asia Pacific

Track 14: Hematology Nursing

Hematology nursing is a different aspect in nursing where assistance and care for patients with blood diseases and disorders is dealt with. Haematology nurses may also assist in blood tests, transfusions, chemotherapy and other diagnostic and treatments related to blood such as leukaemia, lymphoma, sickle cell anaemiaHodgkin’s disease and haemophilia. A haematology nurse has responsibilities very similar to an oncology nurse. Haematology nurses involve in both direct and indirect patient care. Direct care involves diagnostic and treatment aspects. Indirect patient care involves information collection and record keeping. Special training is required for Haematology nursing. This training is essential for dealing with sensitive issues such as IV infusions, catheter insertion etc.

  • Hematology nursing products.
  • Paediatric hematology products.
  • Clinical hematology nursing.
  • Blood cancer pain management.
  • Surgical hematology nursing.

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Conference 2020 | International Conference on Hematology  | Hematology Medical Oncology Conference | Hematological Malignances Conference | Blood Conferences | World Hematologists Congress | Hematology Conference 2020 Asia Pacific

Track 15: Biomarkers in Hematology

Biomarkers in hematology were mostly of protein biomarkers which are helpful to detect the tumours early location and mainly to identify bosom growth, these biomarkers simply used to measure and indicate the severity level of disease state. Where as these haematological biomarkers are helpful in identifying the blood disease. Patients who are suspected with pancreatic malignancy will face CT sweep. Recolors neoplastic pancreatic cells will empower the certainty to identify pancreatic tumour by pathologist and hence suitable for treating disease condition. For pancreatic disease a novel drug discovery in biomarkers like 
BI-010 and IHC markers are developed.

  • Drug Targeting.
  • Prognosis and treatment production.
  • Pharmacodynamics and Pharmacokinetics.
  • Monitoring treatment response.

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Conference 2020 | International Conference on Hematology  | Hematology Medical Oncology Conference | Hematological Malignances Conference | Blood Conferences | World Hematologists Congress | Hematology Conference 2020 Asia Pacific 

 

Market Analysis

Summary

Hematology the branch of medicine that treats blood disorders and diseases which includes various research areas like clinical laboratory, Hematopathology studies, physiology of blood cells immunology, pediatric hematology. Hematology Congress 2020 will be center of interest in various research areas related to hematology and it involves wide range of medical streams this will be best platform for exhibiting your research works, interdisciplinary interactions and sharing of knowledge.

The organizing committee equipping for an exciting and informative conference giving space for plenipotentiary lectures, symposia, poster presentations, workshops on wide ranging concepts of hematology and gearing up various programs for participants from all over the world. We look for you to us at World Summit on Hematology and Cell Therapy 2020, Osaka, Japan. We are sure you will have a meaningful experience with speakers, scholars and researchers from around the globe. All the members and organizing committee of Asian Hematology 2020 look forward to meeting you in Osaka, Japan.

Importance and Scope

International Conference on Hematology and Clinical Pathology 2020 accredit to proffer the best stage for the abilities, researches, specialists and business delegates with its well-planned program covering each moment insight about hematology and blood disorders from the root causes behind blood ailments to the most best therapies in treating blood disorders and diseases this world congress is to give a breakthrough for innovative weapon against incessant clutters such as Thalassemia’s, lymphomas, biomarkers in blood and counter acting agents and antigen responses and to examine the immunological properties of blood which gives knowledge about the root causes.

Hematology Market Study

The world diagnostics and drug market related Hematology are likely ranging from nearly $84.5 billion in 2015 to $122.4 billion in 2020 at a five-year compound annual growth rate of 7.2%. Blood disorders the chief segments for the growth rate to reach nearly $57.3 billion and $78 billion in 2015 and 2020 and including five-year CAGR of 6.7%. Haemato-Oncology is the segment which showing a high growth rate, should raise by almost 23$ billion in 2015 to 37.00$ in 2020 at a five-year CAGR of 9.2%. Taking Reagents and diagnostics as a segment this should reach $6.0 billion in 2020 at a five-year CAGR of 3.0%

The Hematology market in Asia and the middle East is doubling in digits and remains to grown on in the upcoming years. The Americas controlled the huge share of 41.75% of Hematology throughout the worldwide and can be predicted up to $1,810.4 million in 2013, expected to reach $2,479.05 million by 2020, at a CAGR of 6% from 2013 to 2020. Asia is controlling the second largest market share of hematology. Germany is controlling a share of almost 20%. Hematology market in Asia expected to $272.8 million in 2013 and is estimated to grasp over $349.7 million by 2020, at a CAGR of 5.4% from 2013 to 2020. China controlling the largest share of 53% of hematology in Asia and an expected market of $216.0 million in 2013, estimated to earn over $429.1 million by 2020, at a CAGR of 15.4% from 2013 to 2020.

Past Conference Report

Hematology 2019

Conference series LLC LTD organized the 12th World Hematologists Congress. The conference organized with a focus on “Defining a New Outlook and Forefront Research in Hematology” was a great success where eminent keynote speakers from various reputed institutions with their magnificent presence addressed the gathering.

The conference was commenced with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both honorable Guests and members of the Keynote forum. The adepts who promote the theme with their elegant talk were:

C D Atreya - Center for Biologics Evaluation and Research, Food and Drug Administration, USA
Elena Karnaukhova - Center for Biologics Evaluation and Research, Food and Drug Administration, USA
Rosa Visone - G. D’Annunzio University, Italy
Violeta Grajçevci Uka - Clinical University Center of Kosovo, Kosovo

Conference series LLC LTD offers well appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with Conference series LLC LTD and supported the conference in every aspect, without which the conference would not have been possible. Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Hematology 2020,

Conference series LLC LTD would like to announce the commencement of the “World Summit on Hematology and Cell Therapy” to be held during August 07-08, 2020 at Osaka, Japan. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Hematology Research.       

To Collaborate Scientific Professionals around the World

Conference Date August 07-08, 2020

Speaker Opportunity

Supported By

Journal of Blood and Lymph Journal of Oncology Research and treatment

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by